| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Nutritional and Molecular Regulation, Division of Basic Sciences, National Cancer Institute, NIH, Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201 [S. D. H., S. N. P., J. M. P.]; Pathology/Histotechnology Laboratory, Science Applications International Corporation-Frederick, Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201 [D. C. H.]; and Biometry Branch, Division of Cancer Prevention and Control, National Cancer Institute, NIH, Bethesda, Maryland 20892 [C. C. B.]
We reported previously that calorie restriction (CR) delays spontaneous carcinogenesis in p53-deficient (p53-/-) mice, suggesting that CR modulates carcinogenesis by p53-independent mechanisms. To further evaluate the role of p53, we monitored tumor development in p53-/- and wild-type (p53+/+) mice fed ad libitum (AL) or a CR regimen (60% of AL calorie intake). CR delayed tumor mortality in p53-/- and p53+/+ mice (mean time to death, 169 and 648 days, respectively) relative to AL feeding (104 and 470 days). The estimated age-specific cancer death rate AL:CR ratios were 4.3 for p53-/- mice and 4.4 for p53+/+ mice. Thus, despite the accelerated onset of carcinogenesis in p53-/- mice, the tumor-delaying effect of CR was similar in the two genotypes.
1 Supported by NCI Grant CA16672 (to S. D. H.).
2 Present address: Departments of Epidemiology and Carcinogenesis, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 189, Houston, TX 77030-4095.
3 To whom requests for reprints should be addressed, at LNMR, Building 560, Room 12-91, NCI-FCRDC, Frederick, MD 21702-1201.
Received 4/10/97. Accepted 6/ 2/97.
This article has been cited by other articles:
![]() |
U. Tabori and D. Malkin Risk Stratification in Cancer Predisposition Syndromes: Lessons Learned from Novel Molecular Developments in Li-Fraumeni Syndrome Cancer Res., April 1, 2008; 68(7): 2053 - 2057. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Erker, R. Schubert, H. Yakushiji, C. Barlow, D. Larson, J. B. Mitchell, and A. Wynshaw-Boris Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor Hum. Mol. Genet., June 15, 2005; 14(12): 1699 - 1708. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Patel, N. P. Nunez, S. N. Perkins, J. C. Barrett, and S. D. Hursting Effects of Energy Balance on Cancer in Genetically Altered Mice J. Nutr., December 1, 2004; 134(12): 3394S - 3398S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Hursting, J. A. Lavigne, D. Berrigan, L. A. Donehower, B. J. Davis, J. M. Phang, J. C. Barrett, and S. N. Perkins Diet-Gene Interactions in p53-Deficient Mice: Insulin-like Growth Factor-1 as a Mechanistic Target J. Nutr., September 1, 2004; 134(9): 2482S - 2486S. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schubert, L. Erker, C. Barlow, H. Yakushiji, D. Larson, A. Russo, J. B. Mitchell, and A. Wynshaw-Boris Cancer chemoprevention by the antioxidant tempol in Atm-deficient mice Hum. Mol. Genet., August 15, 2004; 13(16): 1793 - 1802. [Abstract] [Full Text] [PDF] |
||||
![]() |
Diet-Gene Interactions in p53-Deficient Mice: IGF-1 as a Molecular Target: STEPHEN D. HURSTING, 1 JACKIEA. LAVIGNE,1 DAVIDBERRIGAN,1 BARBARA J. DAVIS,2 LARRY A. DONEHOWER,3 J. CARL BARRETT,1 AND SUSAN N. PERKINS, 1 1 National Cancer Institute, Bethesda, Maryland 20892; 2National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, 27709; 3Baylor College of Medicine, Houston, Texas 77030 Toxicol Pathol, January 1, 2004; 32(1): 140 - 141. [PDF] |
||||
![]() |
Z.D. Sharp, W.-H. Lee, A. Y. Nikitin, A. Flesken-Nikitin, Y. Ikeno, R. Reddick, A. G. Richardson, and J. F. Nelson Minimal effects of dietary restriction on neuroendocrine carcinogenesis in Rb+/- mice Carcinogenesis, February 1, 2003; 24(2): 179 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Tsao, S. Dudley, B. Kwok, A. E. Nickel, P. W. Laird, K. D. Siegmund, R. M. Liskay, and D. Shibata Diet, cancer and aging in DNA mismatch repair deficient mice Carcinogenesis, November 1, 2002; 23(11): 1807 - 1810. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Platz Energy Imbalance and Prostate Cancer J. Nutr., November 1, 2002; 132(11): 3471S - 3481. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Willis and N. H. Colburn Molecular Targets for Cancer Prevention: A Meeting Review of the Third American Cancer Society-Schilling Research Conference Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 972 - 978. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang, J. Li, L. E. Lantry, Y. Wang, R. W. Wiseman, R. A. Lubet, and M. You p53 Transgenic Mice Are Highly Susceptible to 1, 2-Dimethylhydrazine-induced Uterine Sarcomas Cancer Res., June 1, 2002; 62(11): 3024 - 3029. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Berrigan, S. N. Perkins, D. C. Haines, and S. D. Hursting Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice Carcinogenesis, May 1, 2002; 23(5): 817 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Hursting, S. N. Perkins, J. M. Phang, and J. C. Barrett Diet and Cancer Prevention Studies in p53-Deficient Mice J. Nutr., November 1, 2001; 131(11): 3092S - 3094. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Haines, S. Chattopadhyay, and J. M. Ward Pathology of Aging B6;129 Mice Toxicol Pathol, October 1, 2001; 29(6): 653 - 661. [Abstract] [PDF] |
||||
![]() |
S. D. Hursting, S. N. Perkins, L. A. Donehower, and B. J. Davis Cancer Prevention Studies in p53-Deficient Mice Toxicol Pathol, January 1, 2001; 29(1): 137 - 141. [Abstract] [PDF] |
||||
![]() |
H. L. Poetschke, D. B. Klug, S. N. Perkins, T. T.Y. Wang, E. R. Richie, and S. D. Hursting Effects of calorie restriction on thymocyte growth, death and maturation Carcinogenesis, November 1, 2000; 21(11): 1959 - 1964. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Hursting, T. J. Slaga, S. M. Fischer, J. DiGiovanni, and J. M. Phang Mechanism-Based Cancer Prevention Approaches: Targets, Examples, and the Use of Transgenic Mice J Natl Cancer Inst, February 3, 1999; 91(3): 215 - 225. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |